KEGG   PATHWAY: mjv05211
Entry
mjv05211                    Pathway                                
Name
Renal cell carcinoma - Manis javanica (Malayan pangolin)
Description
Renal cell cancer (RCC) accounts for ~3% of human malignancies and its incidence appears to be rising. Although most cases of RCC seem to occur sporadically, an inherited predisposition to renal cancer accounts for 1-4% of cases. RCC is not a single disease, it has several morphological subtypes. Conventional RCC (clear cell RCC) accounts for ~80% of cases, followed by papillary RCC (10-15%), chromophobe RCC (5%), and collecting duct RCC (<1%). Genes potentially involved in sporadic neoplasms of each particular type are VHL, MET, BHD, and FH respectively. In the absence of VHL, hypoxia-inducible factor alpha (HIF-alpha) accumulates, leading to production of several growth factors, including vascular endothelial growth factor and platelet-derived growth factor. Activated MET mediates a number of biological effects including motility, invasion of extracellular matrix, cellular transformation, prevention of apoptosis and metastasis formation. Loss of functional FH leads to accumulation of fumarate in the cell, triggering inhibition of HPH and preventing targeted pVHL-mediated degradation of HIF-alpha. BHD mutations cause the Birt-Hogg-Dube syndrome and its associated chromophobe, hybrid oncocytic, and conventional (clear cell) RCC.
Class
Human Diseases; Cancer: specific types
Pathway map
mjv05211  Renal cell carcinoma
mjv05211

Disease
H00021  Renal cell carcinoma
Organism
Manis javanica (Malayan pangolin) [GN:mjv]
Gene
108383320  PRCC; proline-rich protein PRCC isoform X1 [KO:K13105]
108383561  PIK3R2; phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649]
108383720  TGFB1; transforming growth factor beta-1 proprotein isoform X1 [KO:K13375]
108384279  PAK1; serine/threonine-protein kinase PAK 1 [KO:K04409] [EC:2.7.11.1]
108385046  MAP2K2; dual specificity mitogen-activated protein kinase kinase 2 isoform X3 [KO:K04369] [EC:2.7.12.2]
108385648  SOS1; son of sevenless homolog 1 isoform X1 [KO:K03099]
108385913  CDKN1A; cyclin-dependent kinase inhibitor 1 [KO:K06625]
108386817  JUN; transcription factor Jun [KO:K04448]
108386977  FH; fumarate hydratase, mitochondrial [KO:K01679] [EC:4.2.1.2]
108387830  BRAF; serine/threonine-protein kinase B-raf isoform X1 [KO:K04365] [EC:2.7.11.1]
108387980  EGLN3; prolyl hydroxylase EGLN3 [KO:K09592] [EC:1.14.11.29]
108388206  TGFA; protransforming growth factor alpha isoform X1 [KO:K08774]
108388379  ELOB; elongin-B [KO:K03873]
108388523  ARNT2; aryl hydrocarbon receptor nuclear translocator 2 isoform X1 [KO:K15589]
108390365  PIK3CD; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
108390475  PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X2 [KO:K02649]
108390484  AKT2; RAC-beta serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:2.7.11.1]
108391169  PAK2; serine/threonine-protein kinase PAK 2 [KO:K04410] [EC:2.7.11.1]
108391531  CDC42; cell division control protein 42 homolog isoform X1 [KO:K04393]
108391550  FLCN; folliculin isoform X1 [KO:K09594]
108391894  SOS2; son of sevenless homolog 2 isoform X1 [KO:K03099]
108392139  MAP2K1; dual specificity mitogen-activated protein kinase kinase 1 isoform X1 [KO:K04368] [EC:2.7.12.2]
108392849  PTPN11; tyrosine-protein phosphatase non-receptor type 11 isoform X1 [KO:K07293] [EC:3.1.3.48]
108392914  CUL2; cullin-2 isoform X2 [KO:K03870]
108393746  AKT3; RAC-gamma serine/threonine-protein kinase isoform X2 [KO:K04456] [EC:2.7.11.1]
108394258  PAK5; serine/threonine-protein kinase PAK 5 [KO:K05736] [EC:2.7.11.1]
108394315  EP300; histone acetyltransferase p300 isoform X1 [KO:K04498] [EC:2.3.1.48]
108394317  RBX1; E3 ubiquitin-protein ligase RBX1 isoform X1 [KO:K03868] [EC:2.3.2.32]
108394341  RAF1; RAF proto-oncogene serine/threonine-protein kinase isoform X1 [KO:K04366] [EC:2.7.11.1]
108394533  CRK; adapter molecule crk isoform X1 [KO:K04438]
108394887  EGLN1; egl nine homolog 1 isoform X1 [KO:K09592] [EC:1.14.11.29]
108395362  CREBBP; CREB-binding protein isoform X1 [KO:K04498] [EC:2.3.1.48]
108395451  PAK4; serine/threonine-protein kinase PAK 4 isoform X1 [KO:K05734] [EC:2.7.11.1]
108395546  RAP1A; ras-related protein Rap-1A [KO:K04353]
108395842  KRAS; GTPase KRas isoform X1 [KO:K07827]
108395975  PIK3R3; phosphatidylinositol 3-kinase regulatory subunit gamma isoform X2 [KO:K02649]
108396229  TFE3; transcription factor E3 isoform X1 [KO:K09105]
108397360  PDGFB; platelet-derived growth factor subunit B isoform X1 [KO:K17386]
108397433  AKT1; RAC-alpha serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
108397735  EGLN2; prolyl hydroxylase EGLN2 isoform X1 [KO:K09592] [EC:1.14.11.29]
108398047  NRAS; GTPase NRas [KO:K07828]
108398454  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
108398550  ARAF; serine/threonine-protein kinase A-Raf isoform X2 [KO:K08845] [EC:2.7.11.1]
108399212  HGF; hepatocyte growth factor isoform X1 [KO:K05460]
108399322  MET; hepatocyte growth factor receptor isoform X1 [KO:K05099] [EC:2.7.10.1]
108400388  PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform isoform X3 [KO:K00922] [EC:2.7.1.153]
108400653  GRB2; growth factor receptor-bound protein 2 [KO:K04364]
108400663  MAPK1; mitogen-activated protein kinase 1 isoform X1 [KO:K04371] [EC:2.7.11.24]
108400860  ELOC; elongin-C [KO:K03872]
108403151  TGFB2; transforming growth factor beta-2 proprotein isoform X1 [KO:K13376]
108404522  HIF1A; hypoxia-inducible factor 1-alpha [KO:K08268]
108404608  TGFB3; transforming growth factor beta-3 proprotein isoform X1 [KO:K13377]
108405695  [KO:K07293] [EC:3.1.3.48]
108406403  EPAS1; endothelial PAS domain-containing protein 1 isoform X1 [KO:K09095]
108406544  PIK3CA; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922] [EC:2.7.1.153]
108406715  SLC2A1; solute carrier family 2, facilitated glucose transporter member 1 [KO:K07299]
108406801  RAPGEF1; rap guanine nucleotide exchange factor 1 isoform X18 [KO:K06277]
108407135  VEGFA; vascular endothelial growth factor A, long form [KO:K05448]
108407356  RAP1B; ras-related protein Rap-1b [KO:K07836]
108407571  BAD; bcl2-associated agonist of cell death isoform X1 [KO:K02158]
108407595  RAC1; ras-related C3 botulinum toxin substrate 1 isoform X1 [KO:K04392]
108408262  ARNT; aryl hydrocarbon receptor nuclear translocator isoform X1 [KO:K09097]
108408627  HRAS; GTPase HRas isoform X1 [KO:K02833]
108408853  ETS1; protein C-ets-1 isoform X2 [KO:K02678]
108408988  CRKL; crk-like protein [KO:K04438]
108409341  GAB1; GRB2-associated-binding protein 1 isoform X6 [KO:K09593]
108409892  PAK3; serine/threonine-protein kinase PAK 3 isoform X3 [KO:K05733] [EC:2.7.11.1]
118966805  PAK6; serine/threonine-protein kinase PAK 6 [KO:K05735] [EC:2.7.11.1]
118967667  [KO:K02833]
140842982  [KO:K02833]
140843067  [KO:K02833]
Compound
C00007  Oxygen
C00122  Fumarate
C00149  (S)-Malate
Reference
  Authors
Cohen HT, McGovern FJ.
  Title
Renal-cell carcinoma.
  Journal
N Engl J Med 353:2477-90 (2005)
DOI:10.1056/NEJMra043172
Reference
  Authors
Pavlovich CP, Schmidt LS.
  Title
Searching for the hereditary causes of renal-cell carcinoma.
  Journal
Nat Rev Cancer 4:381-93 (2004)
DOI:10.1038/nrc1364
Reference
  Authors
Linehan WM, Walther MM, Zbar B.
  Title
The genetic basis of cancer of the kidney.
  Journal
J Urol 170:2163-72 (2003)
DOI:10.1097/01.ju.0000096060.92397.ed
Reference
  Authors
Kim WY, Kaelin WG.
  Title
Role of VHL gene mutation in human cancer.
  Journal
J Clin Oncol 22:4991-5004 (2004)
DOI:10.1200/JCO.2004.05.061
Reference
  Authors
Sudarshan S, Linehan WM, Neckers L.
  Title
HIF and fumarate hydratase in renal cancer.
  Journal
Br J Cancer 96:403-7 (2007)
DOI:10.1038/sj.bjc.6603547
Reference
  Authors
Sudarshan S, Pinto PA, Neckers L, Linehan WM.
  Title
Mechanisms of disease: hereditary leiomyomatosis and renal cell cancer--a distinct form of hereditary kidney cancer.
  Journal
Nat Clin Pract Urol 4:104-10 (2007)
DOI:10.1038/ncpuro0711
Reference
  Authors
Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF.
  Title
Met, metastasis, motility and more.
  Journal
Nat Rev Mol Cell Biol 4:915-25 (2003)
DOI:10.1038/nrm1261
Reference
  Authors
Muller-Hocker J, Babaryka G, Schmid I, Jung A
  Title
Overexpression of cyclin D1, D3, and p21 in an infantile renal carcinoma with Xp11.2 TFE3-gene fusion.
  Journal
Pathol Res Pract 204:589-97 (2008)
DOI:10.1016/j.prp.2008.01.010
Reference
  Authors
Bodmer D, van den Hurk W, van Groningen JJ, Eleveld MJ, Martens GJ, Weterman MA, van Kessel AG.
  Title
Understanding familial and non-familial renal cell cancer.
  Journal
Hum Mol Genet 11:2489-98 (2002)
DOI:10.1093/hmg/11.20.2489
Reference
  Authors
Kauffman EC, Ricketts CJ, Rais-Bahrami S, Yang Y, Merino MJ, Bottaro DP, Srinivasan R, Linehan WM
  Title
Molecular genetics and cellular features of TFE3 and TFEB fusion kidney cancers.
  Journal
Nat Rev Urol 11:465-75 (2014)
DOI:10.1038/nrurol.2014.162
Reference
  Authors
Skalsky YM, Ajuh PM, Parker C, Lamond AI, Goodwin G, Cooper CS
  Title
PRCC, the commonest TFE3 fusion partner in papillary renal carcinoma is associated with pre-mRNA splicing factors.
  Journal
Oncogene 20:178-87 (2001)
DOI:10.1038/sj.onc.1204056
Reference
  Authors
Medendorp K, van Groningen JJ, Vreede L, Hetterschijt L, Brugmans L, van den Hurk WH, van Kessel AG
  Title
The renal cell carcinoma-associated oncogenic fusion protein PRCCTFE3 provokes p21 WAF1/CIP1-mediated cell cycle delay.
  Journal
Exp Cell Res 315:2399-409 (2009)
DOI:10.1016/j.yexcr.2009.04.022
Related
pathway
mjv00020  Citrate cycle (TCA cycle)
mjv04010  MAPK signaling pathway
mjv04066  HIF-1 signaling pathway
mjv04120  Ubiquitin mediated proteolysis
mjv04350  TGF-beta signaling pathway
mjv04370  VEGF signaling pathway
KO pathway
ko05211   

DBGET integrated database retrieval system